Dolinger .2024 .Crohn's disease.” The Lancet. , 6736(23) : 02586-2.
Kershaw .2024 .Real-world impact of uncontrolled symptoms and suboptimal treatment response in patients with Crohn's disease in the United States and Europe. Crohn's & Colitis, 7(1) : .
Yuan .2022 .Identification of immune infiltration and cuproptosis-related subgroups in Crohn's disease. ” Frontiers in Immunology, 1074271 : .
Long ,March 2024 . .Crohn's disease and ulcerative colitis: from pathophysiology to novel therapeutic approaches. ” Biomedicines, 12(3) : .
Qari Yahya A. “,January -April .2022 .Clinical characteristics of Crohn's disease in a cohort from Saudi Arabia. Saudi Journal of Medicine & Medical Sciences, 35(1) : 20-62.
Borowitz ,Steven M. “ .2022 .The epidemiology of inflammatory bowel disease: clues to pathogenesis?” Frontiers in Pediatrics. , 1103713 : .
Abdulrhaman D. . .Association of serum biomarker levels transforming growth factor-β and tumor necrosis factorα with diabetic neuropathy. ” Human Antibodies, 32(2024) : 193-199.
Atretkhany ,Konstantin N . .Distinct modes of TNF signaling through its two receptors in health and disease. ” Journal of Leukocyte Biology, 107(6) : 510R-905.
Chen ,Yang .2021 .Interaction between commensal bacteria, immune response and the intestinal barrier in inflammatory bowel disease. ” Frontiers in Immunology, 761981 : .
Owczarek .2012 .TNF α and soluble forms of TNF receptors 1 and 2 in the serum of patients with Crohn's disease and ulcerative colitis. ” Polish Archives of Internal Medicine, 122(12) : 616-623.
Ji .2024 .Association between hs-CRP and depressive symptoms: a cross-sectional study. ” Frontiers in Psychiatry, 1339208 : .
Sands Bruce E.,November 2015 .2015 .Biomarkers of inflammation in inflammatory bowel disease. ” Gastroenterology, 07(5) : 1275-1285.